eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Rosemont Pharmaceuticals Limited

Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours Telephone: +44 (0)7836 557 879
Out of Hours contact: pharmacovigilance@rosemontpharma.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 22/05/2012
PIL Dozic 5mg/5ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 24/03/2010 and displayed until 22/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 11/01/2010 and displayed until 24/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 26/08/2008 and displayed until 11/01/2010
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 10/09/2007 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change of contra-indications
Updated on 21/09/2005 and displayed until 10/09/2007
Reasons for adding or updating:
  • Change to instructions about missed dose
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 25/09/2002 and displayed until 21/09/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   haloperidol